NSEFraud/Default/Arrest20h ago · 15 Sept 2026, 06:35 pm
Fraud/Default/Arrest
Mangalam Drugs And Organics Limited · MANGALAM
✦ AI Summary▼ NegativeDebt Restruc.
Mangalam Drugs And Organics Limited has informed the Exchange about default on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern6/10
Regulatory Risk9/10
Balance Sheet Risk8/10
Liquidity Impact4/10
Market Sentiment1/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest
Attachments (1)
📄pdf
Download →
MANGALAM_15092026183449_SE27.pdf
View document text
Mangalam Drugs and Organics Limited a—
FANCALAM
Regd. Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. 0. Mumbai - 400 001 h___d&
@ 91-22-62616200 / 6300 / 8787 @ 91-22-62619090 o CIN : L24230MH1972PLC116413 vo
REF: MDOL/CS-SE/2026-27/027 September 15", 2026
Listing Department Listing Department
BSE Ltd National Stock Exchange of India
1 Floor, New Trade Wing, Limited
Phiroze Jeejeebhoy Towers, “Exchange Plaza”, 5™ Floor,
Dalal Street, Fort, Plot No. C-1, Block G,
Mumbai - 400 001 Bandra - Kurla Complex,
Bandra(E), Mumbai — 400 051
Scrip Code: 532637 Symbol: MANGALAM
Subject: Disclosure under Regulation 30, Part A of Schedule I of SEBI (Listing Obligation and
Disclosure Requirements) Regulation, 2015 of default on bank loan account
Dear Sir/Madam,
This is with reference to Regulation 30. Part A of Schedule III of SEBI (Listing Obligation and
Disclosure Requirements) Regulation, 2015 whereby a Listed Entity is required to make disclosure to
stock exchange(s) Events which shall be disclosed without any application of the guidelines for
materiality as specified in sub-regulation (4) of regulation (30) Part A (6) Default by a Listed Entity
non-payment of the interest or principal amount in full on the date when the debt has become due and
payable. Explanation 1: In case of revolving facilities like cash credit, an entity would be considered to
be in ‘default’ if the outstanding balance remains continuously in excess of the sanctioned limit or
drawing power, whichever is lower, for more than thirty days.
In view of the said provision, Mangalam Drugs and Organics Limited (the Company) is making
subsequent intimation declaring that the Company has defaulted on its loan obligations to Bank of
Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of your
exchange. As on date, the data is given below:
Sr.No | Loan Account Name of Bank Amount Overdue | Date of start of
Number - Cash Rs. In Lacs as on | Default
Credit A/c. No. 14/09/2026
1 60383561246 Bank of Maharashtra 951.19 17/10/2025
2 04170500000243 Bank of Baroda 606.08 20/10/2025
We are also making arrangements to pay the overdue amount as soon as possible
Kindly take the above and attachment provided by management on your records.
Thanking You,
Yours Faithfully,
For Mangalam Drugs & Organics Limited
Govardhan M. Dhoot
Managing Director
DIN: 01240086
Factory : at Vapi (Gujarat) India @ contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com
wffy
Mangalam Drugs and Organics Limited —4
MANGALAM
Regd. Office : R ®u 91p -a 2m 2 B -u 6i 2ld 6i 1n 6g, 2 03 0rd / F 6l 3oo 0r 0, /2 3 89 7 8P. 7 D @’' M 9e 1l -lo 2 2R -o 6a 2d 6, 1N 9e 0a 9r 0 G #. CP. I N0 . : M Lu 2m 4b 23a 0i M - H 4 10 90 7 20 P01 L. C 116413 WH cD orE edS iteN D
15/09/2026
The Company Secretary
Mangalam Drugs and Organics Ltd.
Mumbai.
Subject : Disclosure of subsequent default on bank loan account
Dear Sir/Madam,
T Lh ti ds hl aet st e dr e fis a f uu lr tt eh de r o t no io tsu r l ole at nt e or b D lt i. g a1 t6 i/ o0 ns2 / t2 o0 2 B6 a na kn d o ft o B i an rf oo dr am y ano du t Bh aa nt k M a ofn g Ma al ha arm a D sr hu tg rs a a fn od r O ar g pa en ri ic os d
exceeding 30 days, as per the regulations of your exchange.
Sr.No Loan Account Name of Bank A Rm so .Iu nn t L aO cv se ar sd ou ne | Date D eo ff a s ut la tr t of
Number - Cash
14/09/2026
21 060 4Cr 3 1e 8 7d 3 0i 5 5t 6 0A 1 0/ 2 0c. 4
6 0N 2o 4.
B Ba an nk
o of
M Ba ah ra or da as htra 9 65 01 6. .1 09
1 27 0/ /1 10 0/ /2 20 02 25 5
Kindly acknowledge the same.
Thanking You,
For Mangalam Drugs and Organics Ltd.,
JeevarrDalvi
Chief Financial Officer.
Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com